Log in

NASDAQ:CGNXCognex Stock Price, Forecast & News

$60.42
+1.37 (+2.32 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$59.65
Now: $60.42
$60.82
50-Day Range
$54.57
MA: $58.53
$63.11
52-Week Range
$35.20
Now: $60.42
$64.28
Volume960,858 shs
Average Volume1.16 million shs
Market Capitalization$10.37 billion
P/E Ratio54.93
Dividend Yield0.36%
Beta1.79
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; Cognex Designer that allows customers to build vision applications with a graphical flowchart-based programming environment; and Cognex ViDi, a deep learning-based image analysis software. It also provides general-purpose vision systems for vision tasks, including part location, identification, measurement, assembly verification, and robotic guidance; and vision sensors for vision applications, such as checking the presence and size of parts comprising In-Sight product line of vision systems and a range of 3D vision systems. In addition, the company offers ID products comprising DataMan image-based barcode readers and barcode verifiers, as well as vision-enabled mobile terminals for industrial barcode reading applications. It sells its products to customers in the consumer electronics and automotive industries, and semiconductor and electronics capital equipment markets through direct sales force, as well as through a network of distributors and integrators. The company was founded in 1981 and is headquartered in Natick, Massachusetts.
Read More
Cognex logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 2.4Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.10 out of 5 stars


Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
Current SymbolNASDAQ:CGNX
CUSIP19242210
Phone508-650-3000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$725.63 million
Cash Flow$1.32 per share
Book Value$7.85 per share

Profitability

Net Income$203.87 million

Miscellaneous

Employees2,267
Market Cap$10.37 billion
Next Earnings Date7/29/2020 (Confirmed)
OptionableOptionable

Receive CGNX News and Ratings via Email

Sign-up to receive the latest news and ratings for CGNX and its competitors with MarketBeat's FREE daily newsletter.

Cognex (NASDAQ:CGNX) Frequently Asked Questions

How has Cognex's stock been impacted by COVID-19 (Coronavirus)?

Cognex's stock was trading at $39.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CGNX shares have increased by 53.4% and is now trading at $60.42. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cognex?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 4 sell ratings, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cognex.

When is Cognex's next earnings date?

Cognex is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Cognex.

How were Cognex's earnings last quarter?

Cognex Co. (NASDAQ:CGNX) released its quarterly earnings results on Monday, April, 27th. The scientific and technical instruments company reported $0.11 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.08 by $0.03. The scientific and technical instruments company earned $167.20 million during the quarter, compared to analyst estimates of $154.89 million. Cognex had a return on equity of 14.96% and a net margin of 26.58%. The business's revenue was down 3.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.17 earnings per share. View Cognex's earnings history.

How often does Cognex pay dividends? What is the dividend yield for Cognex?

Cognex announced a quarterly dividend on Monday, April 27th. Stockholders of record on Friday, May 15th will be paid a dividend of $0.055 per share on Friday, May 29th. This represents a $0.22 annualized dividend and a dividend yield of 0.36%. The ex-dividend date is Thursday, May 14th. View Cognex's dividend history.

When did Cognex's stock split? How did Cognex's stock split work?

Cognex's stock split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly created shares were distributed to shareholders after the closing bell on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

How will Cognex's stock buyback program work?

Cognex announced that its Board of Directors has authorized a stock repurchase plan on Monday, October 29th 2018, which authorizes the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 2.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board of directors believes its stock is undervalued.

What price target have analysts set for CGNX?

11 Wall Street analysts have issued 12-month price targets for Cognex's shares. Their forecasts range from $36.00 to $60.00. On average, they anticipate Cognex's stock price to reach $48.90 in the next twelve months. This suggests that the stock has a possible downside of 19.1%. View analysts' price targets for Cognex.

Has Cognex been receiving favorable news coverage?

News articles about CGNX stock have been trending negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cognex earned a daily sentiment score of -2.2 on InfoTrie's scale. They also gave news headlines about the scientific and technical instruments company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days. View the latest news about Cognex.

Are investors shorting Cognex?

Cognex saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 6,770,000 shares, a drop of 17.6% from the May 31st total of 8,220,000 shares. Based on an average daily trading volume, of 1,340,000 shares, the short-interest ratio is presently 5.1 days. Approximately 4.1% of the shares of the company are short sold. View Cognex's Current Options Chain.

Who are some of Cognex's key competitors?

What other stocks do shareholders of Cognex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cognex investors own include NVIDIA (NVDA), Alibaba Group (BABA), Arista Networks (ANET), Paypal (PYPL), Micron Technology (MU), Netflix (NFLX), Walt Disney (DIS), Advanced Micro Devices (AMD), Activision Blizzard (ATVI) and Skyworks Solutions (SWKS).

Who are Cognex's key executives?

Cognex's management team includes the following people:
  • Dr. Robert J. Shillman, Founder, Exec. Chairman & Chief Culture Officer (Age 72)
  • Mr. Robert J. Willett, CEO, Pres & Exec. Director (Age 51)
  • Mr. John J. Curran, Sr. VP of Fin. & Admin., Treasurer and CFO (Age 53)
  • Ms. Sheila M DiPalma CPA, Sr. VP of Corp. Employee Services & Corp. Officer (Age 52)
  • Ms. Susan Conway, Sr. Director of Investor Relations

What is Cognex's stock symbol?

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

How do I buy shares of Cognex?

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cognex's stock price today?

One share of CGNX stock can currently be purchased for approximately $60.42.

How big of a company is Cognex?

Cognex has a market capitalization of $10.37 billion and generates $725.63 million in revenue each year. The scientific and technical instruments company earns $203.87 million in net income (profit) each year or $1.16 on an earnings per share basis. Cognex employs 2,267 workers across the globe.

What is Cognex's official website?

The official website for Cognex is www.cognex.com.

How can I contact Cognex?

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.